Priyansha Sen Jamwal, MD
Pediatric Medicine · Fairfield
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Jamwal’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A112329 · Current
Licensed to practise in California · since 2010 · expires 2027-09-30 · Bangalore University, Sri Devraj Urs Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 125053836Temporary Medical Permit · since 2007 · expires 2010-07-22Specialty on the licence: PediatricsCancelledNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Medicaid work
$559,966 in 2024
Medicaid paid $559,966 for 15,533 billed services this clinician did in 2024, up to 243 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 2,217 | $557,051 |
| Short return visit | 1,057 | $623 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 246 | $498 |
| Short return visit (20+ min) | 567 | $450 |
| Developmental screening | 258 | $412 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 107 | $172 |
| Screening test, pure tone, air only | 562 | $151 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 284 | $133 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 108 | $111 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 523 | $82 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 270 | $44 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 163 | $36 |
| 2024 | 15,533 | 36 | 243 | $559,966 |
| 2023 | 27,389 | 42 | 303 | $394,126 |
| 2022 | 26,182 | 39 | 254 | $306,568 |
| 2021 | 26,071 | 43 | 266 | $415,510 |
| 2020 | 11,125 | 28 | 265 | $389,769 |
| 2019 | 9,915 | 23 | 270 | $202,485 |
| 2018 | 3,008 | 7 | 239 | $171,314 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 2,598 | $392,347 |
| Short return visit (20+ min) | 971 | $339 |
| Short return visit | 1,224 | $275 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 329 | $263 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 939 | $137 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 303 | $112 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 281 | $88 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 558 | $87 |
| Return visit (30+ min) | 95 | $82 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 176 | $75 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 209 | $66 |
| Screening test, pure tone, air only | 563 | $56 |
2022
| Clinic visit/encounter, all-inclusive | 2,082 | $304,943 |
| Short return visit (20+ min) | 993 | $336 |
| Short return visit | 1,014 | $235 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 266 | $175 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 997 | $151 |
| Return visit (30+ min) | 205 | $123 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 87 | $115 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 41 | $112 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 280 | $75 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 165 | $69 |
| Screening test, pure tone, air only | 529 | $45 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 649 | $36 |
2021
| Clinic visit/encounter, all-inclusive | 2,837 | $412,386 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; second dose | 135 | $1,963 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; first dose | 46 | $512 |
| Short return visit | 2,157 | $218 |
| Short return visit (20+ min) | 600 | $121 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 114 | $112 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 330 | $86 |
| Screening test, pure tone, air only | 499 | $62 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 249 | $18 |
| Bilateral quantitative screening test of visual acuity | 825 | $10 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 140 | $9 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 704 | $9 |
2020
| Clinic visit/encounter, all-inclusive | 2,905 | $389,367 |
| Short return visit | 2,054 | $119 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 428 | $105 |
| Screening test, pure tone, air only | 734 | $67 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 162 | $58 |
| Short return visit (20+ min) | 60 | $26 |
| Bilateral quantitative screening test of visual acuity | 617 | $25 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 301 | $1 |
| TOBACCO NON-USER | 146 | $0 |
| WEIGHT RECORDED | 377 | $0 |
| BODY MASS INDEX DOCD | 377 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 512 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 2,639 | $202,407 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 87 | $56 |
| Short return visit | 1,631 | $21 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 271 | $1 |
| TOBACCO NON-USER | 317 | $0 |
| WEIGHT RECORDED | 370 | $0 |
| BODY MASS INDEX DOCD | 370 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 681 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 674 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 89 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 16 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 52 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 2,239 | $171,143 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 12 | $112 |
| Short return visit | 501 | $59 |
| Screening test, pure tone, air only | 110 | $0 |
| Bilateral quantitative screening test of visual acuity | 105 | $0 |
| OFF/OP EST MAY X REQ PHY/QHP | 29 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 12 | $0 |
Money from drug and device companies
$17 in 2023
| 2023 | 1 | 1 | None | $17 |
| 2022 | 1 | 1 | None | $24 |
| 2021 | 1 | 1 | None | $14 |
| 2020 | 1 | 1 | None | $19 |
| 2019 | 3 | 5 | None | $110 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Shingrix | $17 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2023-03-15 | Shingrix | $17 |
See earlier years (2022, 2021, 2020, 2019)
2022: $24
| GlaxoSmithKline | Bexsero | $24 | 1 payment
|
2021: $14
| GlaxoSmithKline | Boostrix | $14 | 1 payment
|
2020: $19
| GlaxoSmithKline | Pediarix | $19 | 1 payment
|
2019: $110
| GlaxoSmithKline | Bexsero | $67 | 3 payments
|
| Sobi | Synagis | $28 | 1 payment
|
| Merck Sharp & Dohme | Rotateq | $15 | 1 payment
|
Professional record
- NPI
- 1134459852
- Licence
- CA A112329, IL 125053836California A112329: Current · expires 2027-09-30Illinois 125053836: Cancelled
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 2170 E Bidwell St, Folsom, CA, 95630
- NPI first listed
- 2009-12-31
- NPI last updated
- 2013-07-12
This is when the NPI record was last certified, not a medical board exam.